Streamlining Technical Measured on Medical Products to Combat COVID-19

The urgency of effective responses to the COVID-19 pandemic and the reliance of many low-income countries on imports of medical products, requires new approaches to regulation of these products. The challenge will be particularly acute for the new...

Full description

Bibliographic Details
Main Authors:	Jensen, Michael Friis, Sela, Shane, Brenton, Paul, Keyser, John
Format:	Policy Note
Language:	English
Published:	World Bank, Washington, DC 2020
Subjects:	CORONAVIRUS COVID-19 MEDICAL GOODS TRADE NON-TARIFF MEASURES INTERNATIONAL STANDARD TECHNICAL TRADE BARRIER TRADE REGULATION CUSTOMS INSPECTION PRODUCT REGULATION MEDICAL PRODUCT PANDEMIC RESPONSE
Online Access:	http://documents.worldbank.org/curated/en/304931590509092851/Streamlining-Technical-Measured-on-Medical-Products-to-Combat-COVID-19 http://hdl.handle.net/10986/33825

id	okr-10986-33825
recordtype	oai_dc
spelling	okr-10986-338252021-05-25T09:56:34Z Streamlining Technical Measured on Medical Products to Combat COVID-19 Jensen, Michael Friis Sela, Shane Brenton, Paul Keyser, John CORONAVIRUS COVID-19 MEDICAL GOODS TRADE NON-TARIFF MEASURES INTERNATIONAL STANDARD TECHNICAL TRADE BARRIER TRADE REGULATION CUSTOMS INSPECTION PRODUCT REGULATION MEDICAL PRODUCT PANDEMIC RESPONSE The urgency of effective responses to the COVID-19 pandemic and the reliance of many low-income countries on imports of medical products, requires new approaches to regulation of these products. The challenge will be particularly acute for the new tests to identify infection, drugs to alleviate symptoms and machines to aid recovery as well as vaccines that are all expected to be developed in the coming months. Increased transparency, information sharing and greater cooperation among agencies responsible for the approval and inspection of medical goods around the world can help officials in low-income countries implement their mandate more effectively while maximizing efficient access to these commodities. Responsible agencies should focus on implementing technical regulations to protect health and safety, including interception of counterfeit and substandard products, and avoid wasting resources and creating delays by maintaining procedural practices that may be better addressed through alternative risk management strategies or seeking to regulate quality issues, which are best left to the market. Where there is a need to rapidly approve, test and inspect new goods or varieties that have not previously been imported, such as new equipment and medicines, the adoption of mutual recognition and/or equivalence can provide effective mechanisms to avoid regulatory delays while maintaining high levels of safety. 2020-05-29T15:35:21Z 2020-05-29T15:35:21Z 2020-05-21 Policy Note http://documents.worldbank.org/curated/en/304931590509092851/Streamlining-Technical-Measured-on-Medical-Products-to-Combat-COVID-19 http://hdl.handle.net/10986/33825 English Trade and COVID-19 Guidance Note; CC BY 3.0 IGO http://creativecommons.org/licenses/by/3.0/igo World Bank World Bank, Washington, DC Economic & Sector Work Economic & Sector Work :: Policy Note
repository_type	Digital Repository
institution_category	Foreign Institution
institution	Digital Repositories
building	World Bank Open Knowledge Repository
collection	World Bank
language	English
topic	CORONAVIRUS COVID-19 MEDICAL GOODS TRADE NON-TARIFF MEASURES INTERNATIONAL STANDARD TECHNICAL TRADE BARRIER TRADE REGULATION CUSTOMS INSPECTION PRODUCT REGULATION MEDICAL PRODUCT PANDEMIC RESPONSE
spellingShingle	CORONAVIRUS COVID-19 MEDICAL GOODS TRADE NON-TARIFF MEASURES INTERNATIONAL STANDARD TECHNICAL TRADE BARRIER TRADE REGULATION CUSTOMS INSPECTION PRODUCT REGULATION MEDICAL PRODUCT PANDEMIC RESPONSE Jensen, Michael Friis Sela, Shane Brenton, Paul Keyser, John Streamlining Technical Measured on Medical Products to Combat COVID-19
relation	Trade and COVID-19 Guidance Note;
description	The urgency of effective responses to the COVID-19 pandemic and the reliance of many low-income countries on imports of medical products, requires new approaches to regulation of these products. The challenge will be particularly acute for the new tests to identify infection, drugs to alleviate symptoms and machines to aid recovery as well as vaccines that are all expected to be developed in the coming months. Increased transparency, information sharing and greater cooperation among agencies responsible for the approval and inspection of medical goods around the world can help officials in low-income countries implement their mandate more effectively while maximizing efficient access to these commodities. Responsible agencies should focus on implementing technical regulations to protect health and safety, including interception of counterfeit and substandard products, and avoid wasting resources and creating delays by maintaining procedural practices that may be better addressed through alternative risk management strategies or seeking to regulate quality issues, which are best left to the market. Where there is a need to rapidly approve, test and inspect new goods or varieties that have not previously been imported, such as new equipment and medicines, the adoption of mutual recognition and/or equivalence can provide effective mechanisms to avoid regulatory delays while maintaining high levels of safety.
format	Policy Note
author	Jensen, Michael Friis Sela, Shane Brenton, Paul Keyser, John
author_facet	Jensen, Michael Friis Sela, Shane Brenton, Paul Keyser, John
author_sort	Jensen, Michael Friis
title	Streamlining Technical Measured on Medical Products to Combat COVID-19
title_short	Streamlining Technical Measured on Medical Products to Combat COVID-19
title_full	Streamlining Technical Measured on Medical Products to Combat COVID-19
title_fullStr	Streamlining Technical Measured on Medical Products to Combat COVID-19
title_full_unstemmed	Streamlining Technical Measured on Medical Products to Combat COVID-19
title_sort	streamlining technical measured on medical products to combat covid-19
publisher	World Bank, Washington, DC
publishDate	2020
url	http://documents.worldbank.org/curated/en/304931590509092851/Streamlining-Technical-Measured-on-Medical-Products-to-Combat-COVID-19 http://hdl.handle.net/10986/33825
_version_	1764479596793692160

Streamlining Technical Measured on Medical Products to Combat COVID-19

Similar Items